Editors Note: Occasionally, an opportunity comes to our attention at Investment Banking Rules we believe readers like you will find valuable. The message below from one of our partners is one we believe you should take a close look at.

Dear Fellow Investor,

They needed a "drug smuggler" to fight Alzheimer's

All Big Pharma has on the market are drugs that treat the symptoms, not the disease itself. Drugs like Galantamine, which was discovered in the Soviet Union... in the 1950's!

But now a small, publicly traded biotech is racing to the discovery of a lifetime: using a "drug smuggler" to Fight Alzheimer's, Parkinson's and Dementia.

CNBC says this treatment "would help tens of millions of people."

The Wall Street Journal says, "the financial benefits would be massive."

That's enough to send shares of this tiny biotech up 10,000%.

That's if Biogen, Sanofi and Genentech don't take them over first.

They've paid over $1 billion for the rights to work with this "drug smuggler."

Get the stock symbol here >>>

"The Buck Stops Here,"

dylan signature

From time to time, we send special emails or offers to readers who chose to opt-in. We hope you find them useful.

This email sent to you newsletter@newslettercollector.com by InvestmentBankingRules.com on behalf of Platoon Marketers LLC.

Update Profile | Unsubscribe

1151 Walker Rd Dover, DE, 19904, USA